EXECUTIVE ENGAGEMENTS
POOL
INTERACTIONS
PARTICIPANTS
VALIDATIONS
COMPANIES
* Login for a full stack data experience
DATE
JAN 2023
TABLES
148
PAGES
727
EDITION
9
PRICE
USD 4950
CODE
MCP10061
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
What`s New for 2023?
»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
»Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
»Online interactive peer-to-peer collaborative bespoke updates
»Access to our digital archives and MarketGlass Research Platform
»Complimentary updates for one year
Looking Ahead to 2023
The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Global Active Pharmaceutical Ingredients (API) Market to Reach $321.5 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Active Pharmaceutical Ingredients (API) estimated at US$197.4 Billion in the year 2022, is projected to reach a revised size of US$321.5 Billion by 2030, growing at aCAGR of 6.3% over the period 2022-2030. Innovative, one of the segments analyzed in the report, is projected to record 6% CAGR and reach US$217.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Generic segment is readjusted to a revised 6.9% CAGR for the next 8-year period.
The U.S. Market is Estimated at $68.3 Billion, While China is Forecast to Grow at 6.6% CAGR
The Active Pharmaceutical Ingredients (API) market in the U.S. is estimated at US$68.3 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$51.9 Billion by the year 2030 trailing a CAGR of 6.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.6% and 6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.
SELECT PLAYERS
Alkem Laboratories Limited; Albemarle Corporation; Ajinomoto Co., Inc.; Apotex, Inc.; AbbVie, Inc.; Almac Group; Amneal Pharmaceuticals, Inc.; Aspen Pharmacare Holdings Ltd.; Alembic Pharmaceuticals Limited; Amsal Chem Pvt., Ltd.; Arch Pharmalabs Ltd.; AmbioPharm, Inc.; ACIC Pharmaceuticals, Inc.; American Pacific Corporation; ACS Dobfar S.p.A.
SEGMENTS
» Type (Innovative, Generic) » Synthesis (Synthetic, Biotech) » Application (Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic, Other Applications)
GEOGRAPHIES
» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
I. METHODOLOGY |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Impact of Covid-19 and a Looming Global Recession |
Year 2021 in Review and Near-term Outlook |
Prolonged Pandemic, Ukraine-Russia Conflict and Ensuing Economic Disruptions Impact Growth Outlook |
EXHIBIT: World Economic Growth Projections (Real GDP, Annual % Change) for the Years 2021, 2022 and 2023 |
COVID-19 Alters Pharmaceutical Industry and API Production Dynamics |
COVID-19 Exposes US Pharmaceutical Makers to Risk of Supply Shortages, Driving the Need to Revamp Domestic Industry Structure |
Pandemic Leads US to Focus on Stockpiling & Localized Manufacturing to Rectify Supply Chain Flaws |
Revamping Local Production Capacity |
Knock-on Effect of COVID-19 on API Availability Incites Players to Reconfigure Supply Chain |
COVID-19 Pandemic: A Wake-Up Call for API Seekers to Mitigate Supply Risks |
Short-Term Strategies |
Long-Term Strategies |
Unprecedented Global Push to Expedite COVID-19 Vaccine Development to Spur Demand for APIs |
EXHIBIT: Global Percentage of Individuals Vaccinated by Geographic Region for 2021 through 2025 |
EXHIBIT: Number of CMO Sites for Vaccine Production in Select Countries: 2020 |
Competition |
Active Pharmaceutical Ingredients (API) – Global Key Competitors Percentage Market Share in 2022 (E) |
EXHIBIT: Active Pharmaceutical Ingredients (API) Competitor Market Share Scenario Worldwide (in %): 2022E |
EXHIBIT: Competitive Market Presence - Strong/Active/Niche/Trivial for 266 Players Worldwide in 2022 (E) |
Active Pharmaceutical Ingredients: A Prelude |
Global Active Pharmaceutical Ingredients Market Set to Witness Rapid Growth |
Regional Landscape |
North America Dominates the Global API Market |
US CDMOs to Gain from Mounting Concerns Over Excess Reliance On Chinese APIs |
China Continues to Remain a Major Hub |
COVID-19 Brings Europe’s High Reliance on APIs Sourced from Outside under Spotlight |
India Strives to Increase API Production to Attain Self Reliance in Pharmaceutical Production |
Leading Players |
Recent Market Activity |
World Brands |
2. FOCUS ON SELECT PLAYERS |
3. MARKET TRENDS & DRIVERS |
Sustained Increase in Drug R&D Spending to Drive API Market |
EXHIBIT: Pharmaceutical R&D Spending Worldwide (USD Billion): 2015-2025 |
Increased API Sourcing Creates the need for More Scrutiny of Suppliers for Best Quality Products |
Preference for Specialized CDMO Contractors on the Rise |
Strong Rise in Pharmaceutical Sales to Drive Demand |
EXHIBIT: Global Prescription Drug Sales (In US$ Billion) for the Years 2000-2025 |
The AIC Approach for Faster Assessment of Viable Drug Candidates |
Drug Makers Embrace Digital Technology Amidst COVID-19 Crisis |
EXHIBIT: Digital Transformation Spending in US$ Billion in Pharma Sector: 2020 and 2027 |
Demand for HPAPIs on the Rise |
AI Finds Growing Application in Drug Discovery and Development |
Microdosing Beneficial for the Formulation of High Potency Ingredients |
Growing Penetration of Generic Drugs Augments Market Prospects |
EXHIBIT: Leading Drugs Facing Patent Expiry in the US in 2021 |
EXHIBIT: Global Generic Drugs Market Size (in $ Billion) for the Years 2016, 2019, 2020 & 2025 |
Increasing Interest in Biopharmaceuticals Supports Market Demand |
EXHIBIT: Global Biologic Drugs Market Size (in US$ Billion) for the Years 2019, 2022 & 2025 |
Rising Number of Biologics Approvals Augurs Well |
EXHIBIT: The U.S FDA Biologic NME Approvals for Years 2016 through 2021 |
EXHIBIT: Sponsor Market Cap for the FDA-Approved Biologic FDA NMEs (2020) |
Growing Biosimilars Market Create Opportunities for APIs |
EXHIBIT: Global Biosimilars Market in US$ Billion: 2020 & 2025 |
Growing Attention Towards Personalized Medicine Spurs Demand for Complex API |
EXHIBIT: Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025 |
Increasing Sales of OTC Drugs Presents an Opportunity for APIs |
EXHIBIT: Global OTC Drugs Market Breakdown by Product (in %): 2021E |
Growing Prevalence of Infectious Diseases to Spur Growth |
EXHIBIT: Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %) |
EXHIBIT: Global Number of Deaths Caused Due to Communicable Diseases (In 000s) |
Rising Incidence of Cancer & Need to Reduce Cancer-Related Mortality Spell Increased Demand |
EXHIBIT: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040 |
EXHIBIT: Global Breakdown of Total Number of Cancer Cases by Type: 2020 |
Increasing Prevalence of Chronic Disorders Fuels Market Growth |
EXHIBIT: World Diabetes and Population Statistics (2019, 2030 & 2045) |
Rising Incidence of Cardiovascular Diseases Revs Up Opportunities |
EXHIBIT: Hypertension Prevalence (%) Worldwide by Region in Male and Females Aged 25+ Years |
EXHIBIT: Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others |
Upsurge in ANDA Approvals Bodes Well |
Aging Population & Increasing Burden of Chronic Diseases Spurs Pharma Product Sales, Driving Market Growth |
EXHIBIT: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050 |
Novel Technology for Continuous Manufacturing of APIs |
4. GLOBAL MARKET PERSPECTIVE |
World Active Pharmaceutical Ingredients (API) Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030 |
World Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Active Pharmaceutical Ingredients (API) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Innovative by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Innovative by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Innovative by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Generic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Generic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Generic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Synthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Synthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Synthetic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Biotech by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Cardiovascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Endocrinology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Endocrinology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Endocrinology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for CNS & Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for CNS & Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for CNS & Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Gastroenterology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Gastroenterology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Gastroenterology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Orthopedic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Orthopedic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Orthopedic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
III. MARKET ANALYSIS |
UNITED STATES |
Market Facts & Figures |
Active Pharmaceutical Ingredients (API) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E) |
USA Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Type - Innovative and Generic - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
USA Historic Review for Active Pharmaceutical Ingredients (API) by Type - Innovative and Generic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
USA 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Type - Percentage Breakdown of Value Sales for Innovative and Generic for the Years 2014, 2023 & 2030 |
USA Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Synthesis - Synthetic and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
USA Historic Review for Active Pharmaceutical Ingredients (API) by Synthesis - Synthetic and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
USA 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Synthesis - Percentage Breakdown of Value Sales for Synthetic and Biotech for the Years 2014, 2023 & 2030 |
USA Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Application - Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
USA Historic Review for Active Pharmaceutical Ingredients (API) by Application - Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
USA 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications for the Years 2014, 2023 & 2030 |
CANADA |
Canada Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Type - Innovative and Generic - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Canada Historic Review for Active Pharmaceutical Ingredients (API) by Type - Innovative and Generic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Canada 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Type - Percentage Breakdown of Value Sales for Innovative and Generic for the Years 2014, 2023 & 2030 |
Canada Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Synthesis - Synthetic and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Canada Historic Review for Active Pharmaceutical Ingredients (API) by Synthesis - Synthetic and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Canada 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Synthesis - Percentage Breakdown of Value Sales for Synthetic and Biotech for the Years 2014, 2023 & 2030 |
Canada Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Application - Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Canada Historic Review for Active Pharmaceutical Ingredients (API) by Application - Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Canada 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications for the Years 2014, 2023 & 2030 |
JAPAN |
Japan Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Type - Innovative and Generic - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Japan Historic Review for Active Pharmaceutical Ingredients (API) by Type - Innovative and Generic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Japan 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Type - Percentage Breakdown of Value Sales for Innovative and Generic for the Years 2014, 2023 & 2030 |
Japan Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Synthesis - Synthetic and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Japan Historic Review for Active Pharmaceutical Ingredients (API) by Synthesis - Synthetic and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Japan 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Synthesis - Percentage Breakdown of Value Sales for Synthetic and Biotech for the Years 2014, 2023 & 2030 |
Japan Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Application - Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Japan Historic Review for Active Pharmaceutical Ingredients (API) by Application - Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Japan 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications for the Years 2014, 2023 & 2030 |
CHINA |
China Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Type - Innovative and Generic - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
China Historic Review for Active Pharmaceutical Ingredients (API) by Type - Innovative and Generic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
China 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Type - Percentage Breakdown of Value Sales for Innovative and Generic for the Years 2014, 2023 & 2030 |
China Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Synthesis - Synthetic and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
China Historic Review for Active Pharmaceutical Ingredients (API) by Synthesis - Synthetic and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
China 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Synthesis - Percentage Breakdown of Value Sales for Synthetic and Biotech for the Years 2014, 2023 & 2030 |
China Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Application - Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
China Historic Review for Active Pharmaceutical Ingredients (API) by Application - Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
China 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications for the Years 2014, 2023 & 2030 |
EUROPE |
Market Facts & Figures |
Active Pharmaceutical Ingredients (API) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E) |
Europe Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
Europe Historic Review for Active Pharmaceutical Ingredients (API) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Europe 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030 |
Europe Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Type - Innovative and Generic - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Europe Historic Review for Active Pharmaceutical Ingredients (API) by Type - Innovative and Generic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Europe 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Type - Percentage Breakdown of Value Sales for Innovative and Generic for the Years 2014, 2023 & 2030 |
Europe Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Synthesis - Synthetic and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Europe Historic Review for Active Pharmaceutical Ingredients (API) by Synthesis - Synthetic and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Europe 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Synthesis - Percentage Breakdown of Value Sales for Synthetic and Biotech for the Years 2014, 2023 & 2030 |
Europe Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Application - Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Europe Historic Review for Active Pharmaceutical Ingredients (API) by Application - Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Europe 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications for the Years 2014, 2023 & 2030 |
FRANCE |
France Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Type - Innovative and Generic - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
France Historic Review for Active Pharmaceutical Ingredients (API) by Type - Innovative and Generic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
France 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Type - Percentage Breakdown of Value Sales for Innovative and Generic for the Years 2014, 2023 & 2030 |
France Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Synthesis - Synthetic and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
France Historic Review for Active Pharmaceutical Ingredients (API) by Synthesis - Synthetic and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
France 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Synthesis - Percentage Breakdown of Value Sales for Synthetic and Biotech for the Years 2014, 2023 & 2030 |
France Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Application - Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
France Historic Review for Active Pharmaceutical Ingredients (API) by Application - Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
France 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications for the Years 2014, 2023 & 2030 |
GERMANY |
Germany Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Type - Innovative and Generic - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Germany Historic Review for Active Pharmaceutical Ingredients (API) by Type - Innovative and Generic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Germany 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Type - Percentage Breakdown of Value Sales for Innovative and Generic for the Years 2014, 2023 & 2030 |
Germany Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Synthesis - Synthetic and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Germany Historic Review for Active Pharmaceutical Ingredients (API) by Synthesis - Synthetic and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Germany 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Synthesis - Percentage Breakdown of Value Sales for Synthetic and Biotech for the Years 2014, 2023 & 2030 |
Germany Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Application - Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Germany Historic Review for Active Pharmaceutical Ingredients (API) by Application - Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Germany 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications for the Years 2014, 2023 & 2030 |
ITALY |
Italy Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Type - Innovative and Generic - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Italy Historic Review for Active Pharmaceutical Ingredients (API) by Type - Innovative and Generic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Italy 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Type - Percentage Breakdown of Value Sales for Innovative and Generic for the Years 2014, 2023 & 2030 |
Italy Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Synthesis - Synthetic and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Italy Historic Review for Active Pharmaceutical Ingredients (API) by Synthesis - Synthetic and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Italy 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Synthesis - Percentage Breakdown of Value Sales for Synthetic and Biotech for the Years 2014, 2023 & 2030 |
Italy Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Application - Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Italy Historic Review for Active Pharmaceutical Ingredients (API) by Application - Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Italy 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications for the Years 2014, 2023 & 2030 |
UNITED KINGDOM |
UK Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Type - Innovative and Generic - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
UK Historic Review for Active Pharmaceutical Ingredients (API) by Type - Innovative and Generic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
UK 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Type - Percentage Breakdown of Value Sales for Innovative and Generic for the Years 2014, 2023 & 2030 |
UK Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Synthesis - Synthetic and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
UK Historic Review for Active Pharmaceutical Ingredients (API) by Synthesis - Synthetic and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
UK 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Synthesis - Percentage Breakdown of Value Sales for Synthetic and Biotech for the Years 2014, 2023 & 2030 |
UK Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Application - Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
UK Historic Review for Active Pharmaceutical Ingredients (API) by Application - Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
UK 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications for the Years 2014, 2023 & 2030 |
REST OF EUROPE |
Rest of Europe Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Type - Innovative and Generic - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Rest of Europe Historic Review for Active Pharmaceutical Ingredients (API) by Type - Innovative and Generic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Rest of Europe 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Type - Percentage Breakdown of Value Sales for Innovative and Generic for the Years 2014, 2023 & 2030 |
Rest of Europe Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Synthesis - Synthetic and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Rest of Europe Historic Review for Active Pharmaceutical Ingredients (API) by Synthesis - Synthetic and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Rest of Europe 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Synthesis - Percentage Breakdown of Value Sales for Synthetic and Biotech for the Years 2014, 2023 & 2030 |
Rest of Europe Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Application - Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Rest of Europe Historic Review for Active Pharmaceutical Ingredients (API) by Application - Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Rest of Europe 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications for the Years 2014, 2023 & 2030 |
ASIA-PACIFIC |
Asia-Pacific Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Type - Innovative and Generic - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Asia-Pacific Historic Review for Active Pharmaceutical Ingredients (API) by Type - Innovative and Generic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Asia-Pacific 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Type - Percentage Breakdown of Value Sales for Innovative and Generic for the Years 2014, 2023 & 2030 |
Asia-Pacific Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Synthesis - Synthetic and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Asia-Pacific Historic Review for Active Pharmaceutical Ingredients (API) by Synthesis - Synthetic and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Asia-Pacific 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Synthesis - Percentage Breakdown of Value Sales for Synthetic and Biotech for the Years 2014, 2023 & 2030 |
Asia-Pacific Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Application - Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Asia-Pacific Historic Review for Active Pharmaceutical Ingredients (API) by Application - Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Asia-Pacific 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications for the Years 2014, 2023 & 2030 |
REST OF WORLD |
Rest of World Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Type - Innovative and Generic - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Rest of World Historic Review for Active Pharmaceutical Ingredients (API) by Type - Innovative and Generic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Rest of World 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Type - Percentage Breakdown of Value Sales for Innovative and Generic for the Years 2014, 2023 & 2030 |
Rest of World Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Synthesis - Synthetic and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Rest of World Historic Review for Active Pharmaceutical Ingredients (API) by Synthesis - Synthetic and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Rest of World 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Synthesis - Percentage Breakdown of Value Sales for Synthetic and Biotech for the Years 2014, 2023 & 2030 |
Rest of World Recent Past, Current & Future Analysis for Active Pharmaceutical Ingredients (API) by Application - Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Rest of World Historic Review for Active Pharmaceutical Ingredients (API) by Application - Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Rest of World 16-Year Perspective for Active Pharmaceutical Ingredients (API) by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Endocrinology, CNS & Neurology, Oncology, Gastroenterology, Orthopedic and Other Applications for the Years 2014, 2023 & 2030 |
IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com